A Novel Sesquiterpene from Callistephus chinensis Improves Alcohol-Induced Liver Disease by Regulating the AMPK/NF-κB Signaling Pathway and Gut Flora
Molecules · 2025
DOI: 10.3390/molecules30224371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Bingxin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: NF-kappa B, Sesquiterpenes, Liver Diseases, Alcoholic, Signal Transduction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Provincial Department of Education-project, National Natural Science Foundation of China, Liaoning Provincial Science and Technology Program Joint Program.
Abstract (Originalsprache)
Alcoholic liver disease (ALD) caused by excessive alcohol consumption poses a serious threat to human health. Callistephus chinensis (L.) Nees is an herb of the Asteraceae family that has good results in the prevention and treatment of a variety of liver diseases, including multifactorial liver injury, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, liver fibrosis. Sesquiterpenes are thought to be biologically active components that typically have anti-inflammatory, immunomodulatory, and cardioprotective effects. Callistephus A (CA) is a sesquiterpene compound with a rare 6/7 ring skeleton, which has been isolated only from the Callistephus chinensis Nees. However, the mechanism of action of CA on alcoholic liver disease remains unclear. In this study, alcoholic liver mice were fed with 20 and 40 mg/kg CA, respectively, for 11 days. This study showed that CA improved hepatic steatosis and oxidative stress associated with alcohol consumption. CA alleviated liver inflammation by inhibiting the TLR4/MYD88/NF-κB pathway, ameliorating gut imbalance by restoring the abundance of Akkermansia, and restoring short-chain fatty acids in the gut. Transcriptome analysis revealed that CA primarily affects genes involved in lipid metabolism and inflammation. In vitro, by adding inhibitors of TLR4 (TAK-242) and AMPK (Dorsomorphin), it was confirmed that CA alleviates ALD by inhibiting TLR4 and activating AMPK. This study is the first to demonstrate that CA protects against alcoholic liver disease through the regulation of the gut flora and modulation of the AMPK/NF-κB pathway. In conclusion, CA can effectively improve alcoholic liver disease and can be used as an effective candidate drug with liver-protective effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Förderung
- Liaoning Provincial Department of Education-project
- National Natural Science Foundation of China
- Liaoning Provincial Science and Technology Program Joint Program
- Liaoning Provincial Department of Education Youth Project
Zitieren
APA
Zhang, B., Wang, N., Chen, X., Yang, N., Zhao, Y., & Zhang, X. (2025). A Novel Sesquiterpene from Callistephus chinensis Improves Alcohol-Induced Liver Disease by Regulating the AMPK/NF-κB Signaling Pathway and Gut Flora. Molecules. https://doi.org/10.3390/molecules30224371
Vancouver
Zhang B, Wang N, Chen X, Yang N, Zhao Y, Zhang X. A Novel Sesquiterpene from Callistephus chinensis Improves Alcohol-Induced Liver Disease by Regulating the AMPK/NF-κB Signaling Pathway and Gut Flora. Molecules. 2025. doi:10.3390/molecules30224371
BibTeX
@article{Zhang2025,
author = {Zhang, Bingxin and Wang, Ning and Chen, Xiaoxu and Yang, Nan and Zhao, Ying and Zhang, Xiaoshu},
title = {A Novel Sesquiterpene from Callistephus chinensis Improves Alcohol-Induced Liver Disease by Regulating the AMPK/NF-κB Signaling Pathway and Gut Flora},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30224371}
}
EUVIMED